EMBREMMA 0.5MG INJECTION

Introduction:

Embremma 0.5mg Injection consists of the active ingredient Eribulin Mesylate. It is an anti-cancer drug used to treat advanced breast cancer and cancer that develops from fat tissue (liposarcoma). It belongs to the category called non-taxane microtubule dynamics inhibitor. This medicine is prescribed when other chemotherapeutic regimens were tried to which the patient did not respond adequately.

Contact your healthcare provider instantly if you develop symptoms of fever (temperature above 100.5°F), chills, cough, or burning sensation while urinating. These symptoms indicate a severe infection called sepsis.

Uses of Embremma 0.5mg Injection:

• Treatment of metastatic breast cancer and liposarcoma

How Embremma 0.5mg Injection works:

Embremma 0.5mg Injection inhibits the microtubule function and interrupts the phases of the cell cycle. It is active against drug-resistant tumor cells that overexpress P-glycoprotein and causes tumor cell death. Its mode of action is unlike other anti-cancer agents because it suppresses the microtubule growth without affecting the shortening phase. Thus it stops the growth and spread of cancer cells.

Interaction with other drugs:

Inform your doctor about any medications you are taking or have taken before the treatment.

More Information:

Store at 25°C in the original packaging. Do not freeze.

References:

1. Eisai Europe Limited, Electronic Medicines Compendium (EMC), [Revised on Jan 2021] [Accessed on 8th Jul 2021], https://www.medicines.org.uk/emc/files/pil.4517.pdf
2. NerPharMa, US Food & Drug Administration, [Revised on Nov 2010] [Accessed on 8th Jul 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/201532lbl.pdf
3. Shetty and Gupta, Eribulin drug review, South Asian Journal of Cancer, 2014, 3(1), 57-59, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961871/pdf/SAJC-3-57.pdf
4. Edward Chu, Cancer Chemotherapy, Lange’s Basic and Clinical Pharmacology, 14th Edition, 2018, 948-976.

How to use Embremma 0.5mg Injection:

Your physician will calculate the appropriate dose based on your body surface area and inject this medicine into your vein.

Safety Advice:

Pregnancy:

This medicine could cause severe birth defects. Inform your physician before starting this treatment if you are pregnant or think you might be pregnant. 

Breastfeeding: 

Taking this medicine while breastfeeding may not be safe. Consult your physician for advice before breastfeeding during this treatment

Liver:

Inform your physician before starting this treatment if you have liver diseases. Your physician will monitor your liver functions and prescribe accordingly.

Kidney:

Inform your physician before starting this treatment if you have kidney diseases. Your physician will monitor your kidney functions and prescribe accordingly.

Driving: 

Avoid driving or using machinery if you experience side effects like dizziness or tiredness.

Allergies: 

Inform your physician if you experience allergic reactions to eribulin mesylate or other ingredients.

Others:

• Inform your physician before taking this injection if you have fever or infection, heart problems, numbness, tickling or pricking sensations.
• This medicine is not intended for use by children below 18 years of age.
• Women of reproductive age should use an effective method of contraception up to 3 months after this treatment. 

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.

Serious:

• Fever, raising heartbeat, breathlessness, cold and pale skin, confusion
• Allergic reactions
• Severe skin rashes with blisters

Common:

• Low levels of Platelets, WBC and RBC in the blood
• Tiredness or weakness
• Nausea, vomiting, constipation, diarrhea
• Numbness, tingling or prickling sensations
• Loss of appetite, weight loss
• Cough
• Pain in the joints, muscles and back
• Headache
• Hair loss
• Pneumonia and chills
• Vertigo and dizziness
• Eye problems
• Dehydration, dry mouth, cold sores, indigestion, heartburn, stomach pain
• Painful urination and urinary tract infection
• Sore throat, runny nose
• Altered liver functions
• Sleeplessness, depression, changes the sense of taste
• Night sweats
• Blood clots in the lungs
• Swelling
• Nerve problems